Table 3.
Histone modification factors associated with EMT of TNBC.
Histones Modifications Factors | Targets and Pathways | Sense of Dyregulation in TNBC | Role of histone modifications in TNBC | References |
---|---|---|---|---|
TIP60
Lysine acetyltransferase |
Destabilize DNMT1 and inhibit SNAIL2 function leading to the inhibition of DNA methylation of EpCAM promoter region activating the expression of epithelial markers. | Downregulated | Anti-tumoural | [103] |
KDM6A
H3K27me3-demethylase |
Maintenance of CDH1/E-cadherin levels. Role in the MET-associated resolution. Reactivation of bivalent genes by removing H3K27me3 marks deposited during EMT. |
Downregulated | Anti-tumoural | [104] |
EZH2
Histone-lysine N-methyltransferase (H3K27me3) |
Induce the repression of TIMP2 transcription increasing MMP-2 and MMP-9 activity. | Up-regulated | Pro-tumoural | [105] |
LSD1
Lysine demethylase 1 |
Represses E-cadherin expression by demethylating H3K4me at gene’s promoter, during which phosphorylation of LSD1 Ser112 is crucial. | Up-regulated | Pro-tumoural | [106] |
hSETD1A
H3K4 Methyltransferase |
Activates MMPs expression (MMP2, MMP9, MMP12, MMP13, and MMP17). | Up-regulated | Pro-tumoural | [107] |
JMJD5
H3K36me2 demethylase |
Promote cell invasion and induce EMT. Catalyze Snail promoter H3K36me2 demethylation activating its expression. |
Up-regulated | Pro-tumoural | [108] |
KDM5B
Lysine-specific demethylase 5B |
Overexpress MALAT1. Overexpress EMT markers, c-Met, Slug and N-Cadherin, and inhibitis E-Cadherin. |
Up-regulated | Pro-tumoural | [109] |
KDM3A
H3 lysine 9 demethylase 3A |
Promotes the expression of invasive genes by erasing H3K9me2 marks. Regulates the expression of MMP-9 and JUN expressions. |
not evaluated | Pro-tumoural | [110] |
HDAC8
Zinc-dependent class I HDAC |
Enhance TNBC cell migration. Regulates YAP protein levels by decreasing YAP phosphorylation at Ser127. |
not evaluated | Pro-tumoural | [111] |